Thesis
Given the significant downward adjustments in analyst price targets and the mixed Q1 results, I anticipate sustained pressure on Globant's stock. Despite innovative product advancements, the reduction in expectations points to ongoing challenges and potential declines, making it an opportune candidate for a short position.